0001595215-21-000001.txt : 20210105 0001595215-21-000001.hdr.sgml : 20210105 20210105120307 ACCESSION NUMBER: 0001595215-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 EFFECTIVENESS DATE: 20210105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rakuten Medical, Inc. CENTRAL INDEX KEY: 0001595215 IRS NUMBER: 272624716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-385234 FILM NUMBER: 21504463 BUSINESS ADDRESS: STREET 1: 900 CONCAR DR. STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 858-925-5619 MAIL ADDRESS: STREET 1: 900 CONCAR DR. STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 FORMER COMPANY: FORMER CONFORMED NAME: Rakuten Aspyrian, Inc. DATE OF NAME CHANGE: 20180815 FORMER COMPANY: FORMER CONFORMED NAME: Aspyrian Therapeutics, Inc. DATE OF NAME CHANGE: 20131223 D 1 primary_doc.xml X0708 D LIVE 0001595215 Rakuten Medical, Inc. 900 CONCAR DR. SUITE 200 SAN MATEO CA CALIFORNIA 94402 858-925-5619 DELAWARE Rakuten Aspyrian, Inc. Aspyrian Therapeutics, Inc. Corporation true Miguel Garcia-Guzman 900 Concar Dr. Suite 200 San Mateo CA CALIFORNIA 94402 Executive Officer Director Takashi Toraishi 900 Concar Dr. Suite 200 San Mateo CA CALIFORNIA 94402 Executive Officer Director Hiroshi Mikitani 900 Concar Dr. Suite 200 San Mateo CA CALIFORNIA 94402 Executive Officer Director Hiroshi Mori 900 Concar Dr. Suite 200 San Mateo CA CALIFORNIA 94402 Director Carlos Garcia 900 Concar Dr. Suite 200 San Mateo CA CALIFORNIA 94402 Executive Officer David Chao 900 Concar Dr. Suite 200 San Mateo CA CALIFORNIA 94402 Director Kentaro Hyakuno 900 Concar Dr. Suite 200 San Mateo CA CALIFORNIA 94402 Director Brenton Keath 900 Concar Dr. Suite 200 San Mateo CA CALIFORNIA 94402 Executive Officer Biotechnology Decline to Disclose 06b false 2020-12-23 false true true false 0 90000000 90000000 0 false 6 0 0 0 false Rakuten Medical, Inc. /s/ Brenton Keath Brenton Keath Chief Financial Officer 2021-01-05